Table 3.
Desensitization protocols suggested for influenza, measles, tetanus, MMR, DPT, yellow fever, and Pfizer-BioNTech® from 1990 to 2021.
Vaccine | Step | Dose (ml) | Dilution | Time (min) |
---|---|---|---|---|
Influenza (9) | 1 | 0.05 | Full strength | q30 |
2 | 0.1 | Full strength | ||
3 | 0.15 | Full strength | ||
4 | 0.2 | Full strength | ||
Influenza (10) | 1 | 0.05 | 1:100 | q15 |
2 | 0.05 | 1:10 | ||
3 | 0.05 | Full strength | ||
4 | 0.10 | Full strength | ||
5 | 0.15 | Full strength | ||
6 | 0.20 | Full strength | ||
H1N1 Influenza (11) | 1 | 0.05 | 1:10 | q15 |
2 | 0.05 | Full strength | ||
3 | 0.10 | Full strength | ||
4 | 0.15 | Full strength | ||
5 | 0.20 | Full strength | ||
Influenza (12) | 1 | 0.05 | 1:1,000,000 | q30 |
2 | 0.05 | 1:100,000 | ||
3 | 0.05 | 1:10,000 | ||
4 | 0.05 | 1:1,000 | ||
5 | 0.05 | 1:100 | ||
6 | 0.05 | 1:10 | ||
7 | 0.05 | Full strength | ||
8 | 0.05 | Full strength | ||
Pfizer BioNTech (5) | 1 | 0.03 | Full strength | q30 |
2 | 0.07 | Full strength | ||
3 | 0.10 | Full strength | ||
4 | 0.10 | Full strength | ||
Measles (10) | 1 | 0.05 | 1:100 | q15 |
2 | 0.05 | 1:10 | ||
3 | 0.05 | Full strength | ||
4 | 0.05 | Full strength | ||
5 | 0.05 | Full strength | ||
6 | 0.05 | Full strength | ||
7 | 0.05 | Full strength | ||
8 | 0.05 | Full strength | ||
9 | 0.05 | Full strength | ||
10 | 0.05 | Full strength | ||
11 | 0.05 | Full strength | ||
12 | 0.05 | Full strength | ||
Measles, Mumps, and Rubella (13) | 1 | 0.05 | 1:100 | q20 |
2 | 0.5 | 1:10 | ||
3 | 0.05 | Full strength | ||
4 | 0.10 | Full strength | ||
5 | 0.15 | Full strength | ||
6 | 0.20 | Full strength | ||
Tetanus (14) | 1 | 0.02 | 1:1,000 | q20 |
2 | 0.02 | 1:100 | ||
3 | 0.02 | 1:100 | ||
4 | 0.02 | 1:10 | ||
5 | 0.10 | 1:10 | ||
6 | 0.05 | Full strength | ||
7 | 0.10 | Full strength | ||
8 | 0.15 | Full strength | ||
9 | 0.20 | Full strength | ||
Toxoid-containing vaccines (tetanus, diphtheria) (15) | 1 | 0.05 | 1:100 | q20 |
2 | 0.05 | 1:10 | ||
3 | 0.05 | Full strength | ||
4 | 0.10 | Full strength | ||
5 | 0.20 | Full strength | ||
6 | 0.25 | Full strength | ||
Yellow Fever (16) | 1 | 0.1 | 1:1,000 | q30 |
2 | 0.1 | 1:100 | ||
3 | 0.1 | 1:10 | ||
4 | 0.05 | Full strength | ||
5 | 0.1 | Full strength | ||
6 | 0.15 | Full strength | ||
7 | 0.2 | Full strength | ||
Suggested universal desensitization protocol (17) | 1 | 0.05 | 1:10 | q15–20 |
2 | 0.05 | Full strength | ||
3 | 0.10 | Full strength | ||
4 | 0.15 | Full strength | ||
5 | 0.20 | Full strength |